Science Explorer Interactive view Map
Topic · Surgery

Case Reports on Hematomas

Case Reports on Hematomas is a research topic within Surgery. Science Explorer counts 9.3k research works in it since 1950. 6.5% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the management of spontaneous and iatrogenic hematomas, including retroperitoneal and rectus sheath hematomas. The papers discuss conservative management, endovascular intervention, and open surgery as treatment options, particularly in patients undergoing anticoagulant therapy. Additionally, the cluster explores complications such as femoral neuropathy and the differential diagnosis with soft tissue sarcomas.

  • Hematoma
  • Management
  • Endovascular Intervention
  • Conservative Treatment
  • Rectus Sheath Hematoma
  • Anticoagulant Therapy
  • Femoral Neuropathy
  • Embolization
  • Soft Tissue Sarcoma
  • Retroperitoneal Hemorrhage
Research works
9.3k
fractional, since 1950
In the world top 10%
608
per year above
Top-10% rate
6.5%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+17%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Case Reports on Hematomas research?

By volume, the United States and China publish the most (314 and 145 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 314 works
  2. 2 China 145 works
  3. 3 Japan 142 works
  4. 4 India 104 works
  5. 5 Germany 56 works
  6. 6 United Kingdom 52 works
  7. 7 Spain 44 works
  8. 8 Italy 39 works
  9. 9 South Korea 37 works
  10. 10 Türkiye 33 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.5%China: 15.0%Japan: 14.7%India: 10.8%6 others listed: 27.0%33%largest
United States314 · 32.5%China145 · 15.0%Japan142 · 14.7%India104 · 10.8%6 others listed261 · 27.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Case Reports on Hematomas research?

By volume in 2022–2025, Icahn School of Medicine at Mount Sinai publishes the most Case Reports on Hematomas research, followed by All India Institute of Medical Sciences and Mohammed V University.

Where is Case Reports on Hematomas research done?

The largest centres of Case Reports on Hematomas research in 2022–2025 are Tokyo (Japan), New York (United States), Beijing (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Tokyo and New York.

Largest cities, 2022–2025

  1. 1 Tokyo Japan 28 works
  2. 2 New York United States 21 works
  3. 3 Beijing China 19 works
  4. 4 Seoul South Korea 15 works
  5. 5 Moscow Russia 13 works
  6. 6 New Delhi India 13 works
  7. 7 Madrid Spain 12 works
  8. 8 London United Kingdom 11 works
  9. 9 Shanghai China 11 works
  10. 10 Guangzhou China 11 works

Where it is the local speciality

  1. TokyoJP · 27.8 works2.5×
  2. New YorkUS · 21.3 works2.3×
← less than its size predictsmore →

Location quotient: how much more of its research is in Case Reports on Hematomas than the world average.

See Case Reports on Hematomas on the map

Where is the best place to study Case Reports on Hematomas?

Among universities, judged by research, Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Icahn School of Medicine at Mount SinaiUnited States 0.00.0%14.3×9 +135.5%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Case Reports on Hematomas research growing?

Output in 2018–2022 was 17% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Case Reports on Hematomas.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.